.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Merck
Chinese Patent Office
Farmers Insurance
McKinsey
Covington
UBS
US Army
Argus Health
Teva

Generated: September 22, 2017

DrugPatentWatch Database Preview

FONDAPARINUX SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Fondaparinux Sodium, and what generic Fondaparinux Sodium alternatives are available?

Fondaparinux Sodium is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA.

The generic ingredient in FONDAPARINUX SODIUM is fondaparinux sodium. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fondaparinux sodium profile page.

Summary for Tradename: FONDAPARINUX SODIUM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list11
Clinical Trials: see list2,433
Patent Applications: see list898
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FONDAPARINUX SODIUM at DailyMed

Pharmacology for Tradename: FONDAPARINUX SODIUM

Drug ClassFactor Xa Inhibitor
Mechanism of ActionFactor Xa Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
FONDAPARINUX SODIUM
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS091316-001Jul 11, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FONDAPARINUX SODIUM
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS091316-004Jul 11, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FONDAPARINUX SODIUM
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS091316-002Jul 11, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
FONDAPARINUX SODIUM
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS091316-003Jul 11, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Teva
Queensland Health
Fuji
Cantor Fitzgerald
Mallinckrodt
Medtronic
Federal Trade Commission
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot